1. Home
  2. CCCC vs LAW Comparison

CCCC vs LAW Comparison

Compare CCCC & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • LAW
  • Stock Information
  • Founded
  • CCCC 2015
  • LAW 2013
  • Country
  • CCCC United States
  • LAW United States
  • Employees
  • CCCC N/A
  • LAW N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • LAW Computer Software: Prepackaged Software
  • Sector
  • CCCC Health Care
  • LAW Technology
  • Exchange
  • CCCC Nasdaq
  • LAW Nasdaq
  • Market Cap
  • CCCC 104.4M
  • LAW 259.6M
  • IPO Year
  • CCCC 2020
  • LAW 2021
  • Fundamental
  • Price
  • CCCC $1.48
  • LAW $4.67
  • Analyst Decision
  • CCCC Buy
  • LAW Buy
  • Analyst Count
  • CCCC 3
  • LAW 2
  • Target Price
  • CCCC $12.00
  • LAW $6.75
  • AVG Volume (30 Days)
  • CCCC 1.4M
  • LAW 209.4K
  • Earning Date
  • CCCC 07-31-2025
  • LAW 08-07-2025
  • Dividend Yield
  • CCCC N/A
  • LAW N/A
  • EPS Growth
  • CCCC N/A
  • LAW N/A
  • EPS
  • CCCC N/A
  • LAW N/A
  • Revenue
  • CCCC $39,783,000.00
  • LAW $145,923,000.00
  • Revenue This Year
  • CCCC N/A
  • LAW $6.09
  • Revenue Next Year
  • CCCC N/A
  • LAW $6.27
  • P/E Ratio
  • CCCC N/A
  • LAW N/A
  • Revenue Growth
  • CCCC 98.56
  • LAW 3.84
  • 52 Week Low
  • CCCC $1.09
  • LAW $3.31
  • 52 Week High
  • CCCC $7.66
  • LAW $6.64
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 48.83
  • LAW 66.67
  • Support Level
  • CCCC $1.36
  • LAW $4.26
  • Resistance Level
  • CCCC $1.60
  • LAW $4.49
  • Average True Range (ATR)
  • CCCC 0.12
  • LAW 0.17
  • MACD
  • CCCC -0.00
  • LAW 0.03
  • Stochastic Oscillator
  • CCCC 31.58
  • LAW 97.20

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

Share on Social Networks: